Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07231471 · ClinicalTrials.gov registry record · NA

Platelet Rich Plasma for Musculoskeletal Conditions

A NA study of Tendinopathy and Osteoarthritis (OA) of the Knee, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
10,000
Enrollment target
1
Study location

NCT07231471: Recruiting NA study of Tendinopathy and Osteoarthritis (OA) of the Knee, sponsored by University of Utah.

NCT07231471 is a NA study of Tendinopathy and Osteoarthritis (OA) of the Knee that is actively recruiting participants, run by University of Utah. The registered enrollment target is 10,000 participants, above the 67-participant average among 10 other Tendinopathy trials with a reported enrollment target (14825% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07231471, a NA study of Tendinopathy and Osteoarthritis (OA) of the Knee, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
10,000 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.

Primary Outcome

The VAS is a 0 to 10 scale, with zero being no pain and ten being the worst pain imaginable for their condition

Conditions Studied

Tendinopathy Osteoarthritis (OA) of the Knee Osteoarthritis Ankle Osteoarthritis (OA) of the Hip Plantar Fasciitis of Both Feet Osteoarthritis (OA) Osteoarthritis (OA) of the Shoulder Elbow Osteoarthritis Epicondylitis of the Elbow

Interventions

  • BIOLOGICAL Platelet Rich Plasma Injection
  • DEVICE Platelet Rich Plasma Preparation

Study Locations (1)

Utah

  • University of Utah Orthoaedic Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2025-12-29
Est. Completion 2035-01-01
Phase NA
University of Utah

818 total trials

What NCT07231471 shows while recruiting

NCT07231471 is an interventional study that assigns participants to a tested intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 67-participant average among 10 other Tendinopathy trials with a reported enrollment target (14825% higher).

The record links to 9 conditions, with Tendinopathy appearing as the primary indexed condition, and to 2 interventions - of which Platelet Rich Plasma Injection is the first listed.

NCT07231471 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT07231471 about?

NCT07231471 is a clinical study titled "Platelet Rich Plasma for Musculoskeletal Conditions". The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will de...

What is the current status of trial NCT07231471?

This trial is currently recruiting. It is a NA study. The enrollment target is 10,000 participants. The study started on 2025-12-29. Estimated completion is 2035-01-01.

What conditions does trial NCT07231471 study?

This clinical trial studies the following conditions: Tendinopathy, Osteoarthritis (OA) of the Knee, Osteoarthritis Ankle, Osteoarthritis (OA) of the Hip, Plantar Fasciitis of Both Feet.

What interventions are being tested in trial NCT07231471?

The interventions under investigation include: Platelet Rich Plasma Injection (BIOLOGICAL), Platelet Rich Plasma Preparation (DEVICE).

Who is sponsoring clinical trial NCT07231471?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07231471 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tendinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07231471's enrollment target sits among peer trials

10,000 1st of 10 higher than 10 of 10 other Tendinopathy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tendinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07231471

Source: ClinicalTrials.gov NCT07231471, the US trial registry maintained by the National Library of Medicine. NCT07231471 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.